Application of dental pulp stem cell exosome in preparation of bone injury repair preparation

Stimulating the endodontic stem cells through Staphylococcus aureus lysates, increasing the secretion of exosomes, solving the problem of insufficient secretion of the exosomes in bone injury repair, achieving significant bone injury repair effect, which is better than Conventional exosome set.

CN118987039APending Publication Date: 2024-11-22SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410953071.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The secretion of endodontic stem cell exosomes in bone injury repair is low, resulting in insufficient bone injury repair activity. Stem cell treatment has high cost and tumorigenic risk, so the yield and safety of exosomes need to be improved.

Method used

By stimulating the endodontic stem cells with Staphylococcus aureus lysates, efficient exosomes were prepared, and virulence factors were neutralized with Staphylococcus aureus lysates and rabbit polyclonal antibodies, and the biological organism that significantly increased the secretion of exosomes was obtained. preparation.

Benefits of technology

The secretion amount of endodontic stem cell exosomes and the effect of bone injury repair was significantly improved. The area of ​​skull defect repair in mice 3 weeks after surgery was 83.92% compared with the conventional exosome group, which was better than 56.77% in the model group, proving that golden yellow Significant advantages of staphylococci lysate culture exosomes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987039A_ABST
    Figure CN118987039A_ABST
Patent Text Reader

Abstract

The invention discloses application of a dental pulp stem cell exosome in preparation of a bone injury repair preparation, and belongs to the technical field of biology. The bone fracture injury repairing preparation is a cell exosome obtained by stimulating dental pulp stem cells by using staphylococcus aureus lysate. Compared with the conventionally cultured dental pulp stem cell exosome, the secretion amount of the dental pulp stem cell exosome can be remarkably increased by using the staphylococcus aureus lysate to stimulate. When the exosome is used for mouse bone injury repair, the exosome with the same dosage acts on skull defect repair, and the relative area of the mouse skull defect of the staphylococcus aureus lysate culture exosome group is 83.92% of that of a conventional exosome group and 56.77% of that of a model group after 3 weeks after operation; the bone injury repair effect of the exosome cultured by the staphylococcus aureus lysate is obviously superior to that of a conventional exosome group.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biological technology, and in particular relates to an application of dental pulp stem cell exosomes in the preparation of a bone damage repair preparation. Background Art

[0002] Human bone is dense, anatomically complex, and grows slowly, making repair of injuries a persistent challenge in clinical treatment. Currently, implantable medical devices used for bone repair are primarily derived from natural calf tibia. These products suffer from low repair activity, poor human compatibility, and a high incidence of allergic reactions. Synthetic osteoid substrates also present numerous issues, resulting in unsatisfactory treatment outcomes.

[0003] The healing mechanism of large bone defects is regulated by a variety of inducing factors, including the regulation of osteoblast activity in the early stages and bone formation in the later stages. Stem cells have become an important breakthrough in the medical field due to their unique self-renewal and multidirectional differentiation capabilities. Pluripotent stem cells and dental pulp mesenchymal stem cells can play a promoting role in bone damage repair. At present, the approval of direct stem cell treatment is still cautious to a certain extent. The birth of pluripotent stem cells has broken through the important ethical barriers to clinical transformation during the embryonic stem cell research period. Its safety has also been recognized to a certain extent, but at this stage, stem cell treatment still has the problem of high cost, which is reflected in the cost of stem cell storage and transportation and the risks during the process. The risks of inducing tumors that may arise during the stem cell treatment process also need further research and optimization. Recent advances in exosome research have greatly improved the safety of stem cell use and broadened its application channels. Exosomes are extracellular lipid nanovesicles, approximately 30 to 150 nm in size. They are actively secreted by most living cells through exocytosis and are present in all body fluids, including plasma, urine, serum, saliva, and cerebrospinal fluid. Exosomes contain a lipid bilayer structure and carry typical transmembrane proteins and receptors, adhesion molecules, lipid raft-associated proteins, and immunomodulatory molecules. A variety of proteins and nucleic acids can be found within the exosome lumen, varying depending on the cell type. As key messengers of intercellular communication, exosomes deliver bioactive molecules to recipient cells, thereby participating in a variety of pathophysiological processes, including cancer, cardiovascular disease, and neurodegenerative diseases.

[0004] Research reports have also pointed out that among the secretory functions of stem cells, exosomes play a major role in paracrine effects. Exosomes have a nanoscale double-layer membrane structure and contain lipids, microRNAs, and proteins that play a key role in intercellular communication. Due to their low immunogenicity and tumorigenicity, as well as their ease of storage and management, exosomes have become an alternative to whole-cell therapy. Dental pulp stem cell exosomes have the potential to play an effective role in bone repair, but conventional cultured stem cell exosomes have low secretion levels and low bone repair activity, which remain to be addressed. Therefore, how to increase the secretion level of dental pulp stem cells and induce dental pulp stem cells to produce exosomes targeted at bone repair are key to the application of dental pulp stem cell exosomes in bone fracture repair preparations. Summary of the Invention

[0005] The purpose of the present invention is to provide an application of dental pulp stem cell exosomes in the preparation of a bone damage repair preparation, thereby utilizing dental pulp stem cell exosomes to better achieve the bone damage repair effect.

[0006] To achieve the above object, the present invention provides the following technical solutions: First, the present invention provides an application of dental pulp stem cell exosomes in the preparation of a bone fracture repair preparation, wherein the bone fracture repair preparation is exosomes produced by dental pulp stem cells under the stimulation of Staphylococcus aureus lysate.

[0007] Furthermore, the method for preparing stem cell exosomes comprises the following steps: (1) Isolation and culture of dental pulp stem cells; (2) Preparation of Staphylococcus aureus lysate; (3) Dental pulp stem cells were passaged into cell culture flasks, with the passage number not exceeding 5 generations and the cell density being 1×10 6 / mL, culture in a carbon dioxide incubator for 24 h until the cell density reaches more than 80%; (4) Add Staphylococcus aureus lysate to the cell flask and continue culturing for 24 hours. Collect the cell culture supernatant and add 1 / 100 volume of Staphylococcus aureus lysate rabbit polyclonal antibody. Incubate in a 37°C constant temperature incubator for 1 hour. Centrifuge at 12,000 rpm for 10 minutes and collect the supernatant.

[0008] (5) The exosome extraction reagent and cell culture supernatant were mixed in a ratio of 1:1. After standing for 16 hours, the precipitate was collected by centrifugation at 12000 rpm for 1 hour, and the exosomes were dissolved in PBS with 1 / 10 volume of the original culture medium.

[0009] Furthermore, the dosage of the Staphylococcus aureus lysate added to the dental pulp stem cell culture medium is 40 μg / mL.

[0010] Furthermore, the method for preparing the Staphylococcus aureus lysate comprises the following steps: (1) Take Staphylococcus aureus (ATCC 25923) stored in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate it at 37℃ for 24 hours.

[0011] (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 37°C and 220 rpm / min for 24 hours.

[0012] (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 1 / 2 of the supernatant, and resuspend the bacterial pellet with 1 / 2 of the original volume of supernatant.

[0013] (4) The resuspended bacterial solution was broken by ultrasonic disruptor, centrifuged at 12000 rpm / min for 5 minutes, and the supernatant was collected.

[0014] (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus aureus lysate. The protein concentration is determined and the solution is stored at 4°C for later use.

[0015] Secondly, the present invention provides a biological preparation for increasing the production of exosomes from dental pulp stem cells, wherein the biological preparation is a lysate of Staphylococcus aureus.

[0016] Furthermore, the added dosage of the biological agent in the dental pulp stem cell culture medium is 40 μg / mL.

[0017] Furthermore, the preparation method of the biological agent comprises the following steps: (1) Take Staphylococcus aureus (ATCC 25923) stored in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate it at 37℃ for 24 hours.

[0018] (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 37°C and 220 rpm / min for 24 hours.

[0019] (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 1 / 2 of the supernatant, and resuspend the bacterial pellet with 1 / 2 of the original volume of supernatant.

[0020] (4) The resuspended bacterial solution was broken by ultrasonic disruptor, centrifuged at 12000 rpm / min for 5 minutes, and the supernatant was collected.

[0021] (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus aureus lysate. The protein concentration is determined and the solution is stored at 4°C for later use.

[0022] The beneficial effects of the present invention are: The present invention cultivates Staphylococcus aureus to prepare a Staphylococcus aureus lysate, uses the Staphylococcus aureus lysate to stimulate dental pulp stem cells to prepare exosomes, then uses a rabbit polyclonal antibody against the Staphylococcus aureus lysate to neutralize the virulence factors in the Staphylococcus aureus lysate, and purifies the exosomes. Compared with conventionally cultured dental pulp stem cell exosomes, the use of Staphylococcus aureus lysate stimulation can significantly increase the secretion of dental pulp stem cell exosomes. When the exosomes are used to repair bone damage in mice, the same dose of exosomes can repair skull defects. Three weeks after surgery, the relative area of ​​skull defects in the group of mice cultured with exosomes from Staphylococcus aureus lysate was 83.92% of that in the group cultured with conventional exosomes and 56.77% of that in the model group. The bone damage repair effect of exosomes cultured with Staphylococcus aureus lysate was significantly better than that of the group cultured with conventional exosomes. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 The results of the cytotoxicity test of Staphylococcus aureus lysate on dental pulp stem cells are shown in Figure 2. Figure 2 The grayscale difference of CD36 protein in dental pulp stem cell exosomes after culture with different concentrations of Staphylococcus aureus lysate; Figure 3 The effect of exosomes on the repair of skull injury in mice. DETAILED DESCRIPTION

[0024] The following is a more detailed description of the present invention, which is illustrated by examples. It should be understood that these examples are merely examples of the present invention, and their purpose is to illustrate the principles and functions of the present invention, but not to limit the scope of protection of the present invention.

[0025] Example 1 Isolation and culture of dental pulp stem cells (1) The teeth collected in our hospital with intact tooth surface and no caries were immersed in PBS containing penicillin and streptomycin, washed repeatedly, and the soft tissues such as the periodontal membrane attached to the root and neck were removed; (2) Use a dental chisel to split the tooth longitudinally along the long axis of the tooth, remove the pulp tissue using sterile tweezers, cut off the 2 mm portion at the tip, and place it in a sterile EP tube; (3) After rinsing with PBS three times, add 500 μl of PBS and mince the pulp tissue with scissors. Place the EP tube in a centrifuge and centrifuge at 1000 rpm / min for 5 minutes. Keep the precipitate and remove the supernatant. (4) Add type I collagenase and place in a carbon dioxide incubator for digestion at 37°C for 45 minutes; (5) Add an appropriate amount of mesenchymal stem cell culture medium to terminate digestion, centrifuge at 1000 rpm / min for 5 min, discard the supernatant, evenly spread the tissue blocks on the bottom of the cell culture dish, add mesenchymal stem cell culture medium, and culture in a carbon dioxide incubator with a CO2 concentration of 5%. Change the culture medium every 2 to 3 days; (6) The first generation human dental pulp stem cells were diluted to a concentration of 10-20 cells / mL, and then the cells were seeded into a 96-well plate with 100 μl per well; (7) After culturing until cell clones appear, use trypsin to digest the cells and pass them down to obtain human dental pulp stem cells. After testing and confirmation, they can be used in subsequent experiments. The stem cells used in this study were from passages 3 to 5.

[0026] Example 2 Preparation of Staphylococcus aureus lysate (1) Take Staphylococcus aureus (ATCC 25923) stored in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate it at 37℃ for 24 hours.

[0027] (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 37°C and 220 rpm / min for 24 hours.

[0028] (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 9 / 10 of the supernatant, and resuspend the bacterial pellet with 1 / 10 of the original volume of supernatant.

[0029] (4) The resuspended bacterial solution was broken by ultrasonic disruptor, centrifuged at 12000 rpm / min for 5 minutes, and the supernatant was collected.

[0030] (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus aureus lysate. The protein concentration is determined and the solution is stored at 4°C for later use.

[0031] Example 3 Preparation of rabbit polyclonal antibodies against Staphylococcus aureus lysate (1) The Staphylococcus aureus lysate prepared in Example 2 was added with ISA201 adjuvant at a volume ratio of 1:1, and the mixture was emulsified using a shearing machine to prepare a water-in-oil-in-water vaccine.

[0032] (2) Five 30-day-old SPF rabbits were injected intramuscularly with 0.5 mL of the vaccine each, with immunization intervals of 14 days. Blood was collected from the heart 14 days after the third immunization. The blood was placed in a 37°C constant temperature incubator for 1 hour and then transferred to a 4°C refrigerator for 1 hour.

[0033] (3) The blood was centrifuged at 3000 rpm / min for 10 min, and the supernatant was filtered through a 0.22 μm filter to obtain the rabbit polyclonal antibody against Staphylococcus aureus lysate.

[0034] Example 4 Detection of the Cytotoxicity of Staphylococcus aureus Lysate on Dental Pulp Stem Cells (1) After the preserved dental pulp stem cells were revived and cultured to the third generation, the cells were digested to prepare a single cell suspension and inoculated into a 96-well plate. The cells were cultured in a carbon dioxide incubator with a CO2 concentration of 5% until the cell density reached more than 80%.

[0035] (2) Staphylococcus aureus lysate was prepared into Staphylococcus aureus lysate medium with different concentrations: 10 μg / mL, 20 μg / mL, 40 μg / mL, 80 μg / mL, and 160 μg / mL using mesenchymal stem cell culture medium.

[0036] (3) Remove the culture medium in the 96-well cell culture plate and replace it with the Staphylococcus aureus lysate culture medium in step (2). The control group is replaced with the mesenchymal stem cell culture medium.

[0037] (4) After culturing in a cell culture incubator for 24 h, the OD450 value was measured using CCK-8 and the cell viability was calculated. Cell viability = (OD450 of the experimental group - OD450 of the blank control group) / (OD450nm of the control group - OD450 of the blank control group).

[0038] from Figure 1 It can be seen that with the increase of the concentration of Staphylococcus aureus lysate in the range of 10~80μg / mL, the cell survival rate of dental pulp stem cells remained basically stable, and there was no statistically significant difference between the groups. However, the survival rate of dental pulp stem cells in the 160μg / mL Staphylococcus aureus lysate group decreased to 78.00%, indicating that the concentration of Staphylococcus aureus lysate in the culture medium reaching 160μg / mL and above would cause toxicity to dental pulp stem cells.

[0039] Example 5 Preparation of dental pulp stem cell exosomes (1) Dental pulp stem cells were passaged into 75T cell culture flasks with 30 mL of mesenchymal stem cell serum-free medium per flask at a cell density of 1×10 6 / mL, incubate in a CO2 incubator with a 5% CO2 concentration for 24 hours until the cell density reaches above 80%. Groups 1 to 4 were treated with 10 μg / mL, 20 μg / mL, 40 μg / mL, and 80 μg / mL of S. aureus lysate, respectively. Group 5 served as a control, with three replicates per group. Culture was continued for 24 hours. The cell culture supernatant was collected and a 1 / 100 volume of rabbit polyclonal antibody against S. aureus lysate was added. The cells were incubated in a 37°C incubator for 1 hour, centrifuged at 12,000 rpm for 10 minutes, and the supernatant was collected.

[0040] (2) According to the instructions of the exosome extraction kit, the exosome extraction reagent and the above supernatant were mixed in a ratio of 1:1. After standing for 16 hours, the precipitate was collected by centrifugation at 12000 rpm for 1 hour, and the exosomes were dissolved in PBS with 1 / 10 volume of the original culture medium.

[0041] (3) Mix equal volumes of RIPA lysis buffer with exosomes and place on ice for 1 hour, shaking for 1-2 minutes every 10 minutes. Centrifuge at 12000 rpm for 15 minutes at 4°C and collect the supernatant. Mix the sample with 2× Loading buffer at a volume ratio of 1:1 and boil in a water bath for 10 minutes. Perform SDS-PAGE electrophoresis on the prepared sample, transfer it to a PVDF membrane, block it with 5% skim milk powder solution for 1 hour, and use anti-mouse CD63 (ab217345) and GAPDH antibody (ab9485) purchased from Abcam, incubate at 37°C for 1 hour, rinse three times with PBS; use goat anti-rabbit secondary antibody (ab150077) at a dilution of 1:2000, incubate at 37°C for 1 hour, rinse three times with PBS; finally, use ECL luminescence reagent for color development and exposure. Quantity One v462 software was used to analyze the protein gray value and compared with the internal reference protein band to obtain the relative gray ratio. The gray value of the target protein = the OD value of the target protein / the OD value of the corresponding internal reference protein.

[0042] from Figure 2 It can be seen that the amount of exosome marker protein CD63 produced by dental pulp stem cells cultured in the culture medium supplemented with 10 μg / mL, 20 μg / mL, and 40 μg / mL Staphylococcus aureus lysate showed a significant increasing trend with the increase of Staphylococcus aureus lysate concentration, while there was no statistically significant difference in the amount of exosome marker protein CD63 produced by dental pulp stem cells cultured in the 40 μg / mL and 80 μg / mL Staphylococcus aureus lysate groups.

[0043] Example 6 Bone damage repair effect of dental pulp stem cell exosomes (1) Thirty three-month-old Kunming mice were randomly divided into three groups, with 10 mice in each group.

[0044] (2) Each mouse was weighed and anesthetized with 3% pentobarbital solution at a dose of 0.02 mL / g intraperitoneally. The mouse was disinfected with 75% ethanol. The skin was cut open to the subcutaneous fascia layer to expose the skull. A 1 mm diameter defect was made on the right side of the skull at 3 mm from the cranial suture. During the operation, saline was used to cool the mouse and flush out the remaining bone powder. The subcutaneous fascia and skin were sutured layer by layer. The surgical incision was disinfected with 75% ethanol. After surgery, 40×10 4U penicillin was injected continuously for 3 days for anti-infection. Mice were housed in single cages in a clean environment with room temperature of 22-24°C and humidity of 60%. They were given regular water and diet and were allowed to move freely.

[0045] (3) The first group was the bone injury model group. 0.2 mL of sterile PBS was injected into the tail vein of mice 1, 8, and 15 days after surgery. The second group was the conventional exosome group. 0.2 mL of exosomes produced by dental pulp stem cells without Staphylococcus aureus lysate in Example 4 was injected into the tail vein of mice 1, 8, and 15 days after surgery. The third group was the exosome cultured with Staphylococcus aureus lysate group. Exosomes produced by dental pulp stem cells cultured with 100 μg / mL Staphylococcus aureus lysate in Example 4 were diluted with culture medium and diluted to the same gray value of exosome marker protein CD63 as that of the third group. 0.2 mL of exosomes were injected into the tail vein of mice 1, 8, and 15 days after surgery.

[0046] (4) Five mice in each group were randomly killed at 1 week and 3 weeks after surgery, and Micro-CT was performed. Three-dimensional reconstruction was performed using Mimics V17.0 software, and the relative area of ​​the bone defect was calculated using ImageJ software.

[0047] from Figure 3 It can be seen that the relative area of ​​skull defects in the model group was the largest one week after surgery, and the relative areas of skull defects in the conventional exosome group and the Staphylococcus aureus lysate cultured exosome group were smaller than those in the model group. The relative area of ​​skull defects in the Staphylococcus aureus lysate cultured exosome group was 89.65% of that in the conventional exosome group. Three weeks after surgery, the relative areas of skull defects in the three groups of mice were reduced. The relative area of ​​skull defects in the Staphylococcus aureus lysate cultured exosome group was 83.92% of that in the conventional exosome group and 56.77% of that in the model group.

[0048] In summary, dental pulp stem cells cultured with Staphylococcus aureus lysate secreted higher amounts of exosomes than those cultured without Staphylococcus aureus lysate. When exosomes were used to repair bone damage in mice, the same dose of exosomes was effective in repairing skull defects. Three weeks after surgery, the relative area of ​​skull defects in the group receiving exosomes cultured with Staphylococcus aureus lysate was 83.92% of that in the group receiving conventional exosomes and 56.77% of that in the model group. This suggests that exosomes cultured with Staphylococcus aureus significantly outperformed the conventional exosome group in bone repair.

Claims

1. A use of dental pulp stem cell exosomes in the preparation of a bone damage repair preparation, characterized in that: The bone fracture repair preparation is exosomes produced by dental pulp stem cells under the stimulation of Staphylococcus aureus lysate.

2. The use according to claim 1, characterized in that: The method for preparing stem cell exosomes comprises the following steps: (1) Isolation and culture of dental pulp stem cells; (2) preparing Staphylococcus aureus lysate; (3) Dental pulp stem cells were subcultured into cell culture flasks. The number of subcultures did not exceed 5, and the cell subculture density was 1×10 6 / mL, culture in a carbon dioxide incubator for 24 h until the cell density reaches more than 80%; (4) Add Staphylococcus aureus lysate to the cell flask and continue culturing for 24 h. Collect the cell culture supernatant and add 1 / 100 volume of Staphylococcus aureus lysate rabbit polyclonal antibody. Incubate in a 37°C constant temperature incubator for 1 h. Centrifuge at 12,000 rpm for 10 min and collect the supernatant. (5) The exosome extraction reagent and cell culture supernatant were mixed in a ratio of 1:

1. After standing for 16 hours, the precipitate was collected by centrifugation at 12000 rpm for 1 hour, and the exosomes were dissolved in PBS with 1 / 10 volume of the original culture medium.

3. The Staphylococcus aureus lysate according to claim 2, characterized in that The dosage of the Staphylococcus aureus lysate added to the dental pulp stem cell culture medium is 40 μg / mL.

4. The Staphylococcus aureus lysate according to claim 3, characterized in that The preparation method of the Staphylococcus aureus lysate comprises the following steps: (1) Take Staphylococcus aureus (ATCC 25923) frozen in the laboratory, streak it on LB agar plate with an inoculation loop, and incubate at 37°C for 24 hours; (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 220 rpm / min at 37°C for 24 hours. (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 1 / 2 of the supernatant, and resuspend the bacterial pellet with 1 / 2 of the original volume of supernatant; (4) The resuspended bacterial solution was broken by ultrasonic disruptor, centrifuged at 12000 rpm / min for 5 minutes, and the supernatant was collected; (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus aureus lysate. The protein concentration is determined and stored at 4°C for later use.

5. A biological preparation for increasing the production of exosomes from dental pulp stem cells, characterized in that: The biological preparation is Staphylococcus aureus lysate.

6. The biological agent according to claim 5, characterized in that The dosage of the biological agent added to the dental pulp stem cell culture medium is 40 μg / mL.

7. The biological agent according to claim 6, characterized in that The preparation method of the biological agent comprises the following steps: (1) Take Staphylococcus aureus frozen in the laboratory, streak it on LB agar plate with an inoculation loop, and culture it at 37℃ for 24 hours; (2) Pick a circular colony with a whole edge and inoculate it into LB liquid culture medium. Incubate it in a shaker at 220 rpm / min at 37°C for 24 hours. (3) Centrifuge at 12000 rpm / min for 5 minutes, discard 1 / 2 of the supernatant, and resuspend the bacterial pellet with 1 / 2 of the original volume of supernatant; (4) The resuspended bacterial solution was broken by ultrasonic disruptor, centrifuged at 12000 rpm / min for 5 minutes, and the supernatant was collected; (5) The broken bacterial solution is filtered through a 0.22 μm filter to obtain the Staphylococcus aureus lysate. The protein concentration is determined and stored at 4°C for later use.